CRI Awards $29.3 Million to Fund Immunotherapies for All Kinds of Cancer August 6, 2015December 14, 2022 Alexandra Mulvey
European Regulators Approve Pembrolizumab (Keytruda) as First-line Treatment of Advanced Melanoma July 22, 2015December 14, 2022 Matthew Tontonoz
Phase 3 Trial Shows Nivolumab Improves Survival in Advanced Kidney Cancer July 20, 2015December 14, 2022 Matthew Tontonoz
A Cross-Country Biking Trip to Raise Awareness and Funding for Cancer Immunotherapy Research July 15, 2015December 14, 2022 CRI Staff
New Clinical Trials to Offer Immunotherapy as Frontline Treatment for Lung Cancer July 7, 2015December 14, 2022 Matthew Tontonoz